Mattar A, Hegg R, Tayar DO, Rocha M, et al. Prognostic Factors and Survival Outcomes of Patients With Early HER2+ Breast Cancer Treated With Trastuzumab in a Brazilian Public Reference Center: A Real-World Study. Clin Breast Cancer 2023 Sep 7:S1526-8209(23)00216.
PMID: 37802752